SCHEMBL7653154

SCHEMBL7653154

C=CC[C@H](C(=O)NO)[C@@H](CC(C)C)C(=O)N[C@@H](C(=O)OC1CCCC1)c1cccs1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 19/20 0.55
MMP9 P14780 3/20 0.55
ANPEP P15144 2/20 0.55
LTA4H P09960 1/20 0.55
LAP3 P28838 1/20 0.55
NPEPPS P55786 1/20 0.55
ERAP2 Q6P179 1/20 0.55
ERAP1 Q9NZ08 1/20 0.55
MMP3 P08254 17/20 0.52
MMP7 P09237 16/20 0.52
MMP1 P03956 14/20 0.47
MMP8 P22894 2/20 0.47
ADAM17 P78536 1/20 0.47
MMP12 P39900 1/20 0.47
MMP13 P45452 1/20 0.47
MMP14 P50281 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6943166 1.00 MMP2 (0.55) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL6804122 0.86 MMP2 (0.74) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL6801871 0.86 MMP2 (0.74) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL6804119 0.86 MMP2 (0.74) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL7653859 0.84 MMP2 (0.58) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL6941003 0.84 MMP2 (0.58) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL6942503 0.82 MMP2 (0.60) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL7659031 0.82 MMP2 (0.60) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL4420641 0.81 MMP2 (0.51) MMP2MMP9ANPEPLTA4HLAP3
SCHEMBL7883057 0.80 MMP2 (0.70) MMP2MMP9ANPEPLTA4HLAP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462023-B1 SUCH AS 2-HYDROXY-HYDROXYCARBAMOYL-METHYL)-4-METHYL-PENTANOYLAMINE)-2-PHENYL -ETHANOIC ACID CYCLOPENTYL ESTER; INHIBITING HYPERPROLIFERATIVE TUMOURGENIC CELLS SUCH AS MELANOMA AND/OR LYMPHOMA CELLS BRITISH BIOTECH PHARMACEUTICALS, LTD. (GB) 2002-10-08 US claimed